相关实验视频
Updated: Jun 28, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
探索化疗相关认知障碍的新疗法途径
Jorg Dietrich1, Michael W Parsons1,2, Emiliano Santarnecchi1,2,3
1Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
多感官40赫兹马带显示神经保护作用,对与癌症治疗相关的小鼠认知障碍. 这种非侵入性方法可能有助于在经历认知衰退的癌症患者中保持大脑功能.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症患者在治疗期间或之后经常经历认知症状,称为"化学大脑",影响注意力,记忆和执行功能.
- 目前用于化疗相关认知障碍的治疗策略有限,这凸显了对有效干预措施的未满足需求.
- 了解认知衰退的分子机制正在进步,但临床翻译仍然是一个挑战.
研究的目的:
- 在化疗诱导认知障碍的小鼠模型中研究多感官40赫兹马诱导的神经保护潜力.
- 评估联合视觉和听觉刺激在缓解与癌症治疗相关的认知缺陷方面的有效性.
主要方法:
- 使用的小鼠模型接受了西斯普拉丁或甲醇来诱导认知障碍.
- 使用同步的视觉和听觉刺激进行了多感官40Hz马诱导疗法.
- 评估了对大脑结构和功能的神经保护作用.
主要成果:
- 多感官40赫兹马波引入在小鼠模型中显示出显著的神经保护作用.
- 治疗与大脑结构和功能在化学大脑环境中的保存有关.
- 干预的非侵入性质显示出临床应用的前景.
结论:
- 多感应40赫兹马带是一种有前途的非侵入性治疗策略,用于缓解与癌症治疗相关的认知障碍.
- 需要进一步的研究和临床试验来验证这些研究结果在人类患者中.
- 这种方法可以提供一种新的干预措施,以保护癌症幸存者的认知功能.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

